Indeed, compared with Klrk1−/−, tumours in Klrk1+/+ mice proved to express a substantially higher level of the cyclin-dependent kinase inhibitor CDKN1A (p21) (Fig. 8d), a critical player in liver regeneration and hepatocarcinogenesis41. Here, CDKN1A is linked to neoplasm.